·PIB

India Crosses Historic Milestone of 1 Crore HPV Vaccine Doses Administered in Less Than Nine Months, Marking Major Progress in Cervical Cancer Prevention

FlashcardsQuick reviseKey facts. One by one.Start →
In this note
  1. At a Glance
  2. Why in the News
  3. Background & Evolution
  4. Core Static Facts
  5. Multi-Dimensional Analysis
  6. Recent Developments (last 12-18 months)
  7. Prelims Hooks
  8. Who the 87% Leaves Out: Girls Already Past 14
  9. Why Vaccinating Girls Cannot Meet the 2030 Target by Itself
  10. Is One Dose Really Enough?
  11. What Must Come After the Milestone
  12. Anchors for Answers
  13. Mains Relevance
  14. Related Topics to Study Next
  15. NCERT Concepts to Revise
  16. Common Errors / Trap Areas
Practice
8 questions on this item
Check the answer for each question, or reveal all at once.
Practice MCQs →

1. At a Glance

  • National HPV Vaccination Campaign: free, voluntary, single-dose HPV vaccination for 14-year-old girls, given with parental consent at Government health facilities. It is run by the Ministry of Health and Family Welfare (MoHFW) [1].
  • More than 1 crore doses were given in under nine months of the February 2026 launch, and cumulative coverage is nearly 87% of the annual cohort [1].
  • It is primary prevention: persistent infection with high-risk HPV types causes the vast majority of cervical cancer cases [1].
  • Why it matters for UPSC: it brings together health governance (GS-II), women's health and equity (GS-I/II), digital public infrastructure (U-WIN) and global commitments (WHO's 90-70-90 targets) [1][4].

2. Why in the News

  • On 21 Nov 2026, MoHFW announced that more than 1 crore HPV doses had been given in less than nine months [1].
  • Coverage is nearly 87% of an annual target cohort of about 1.2 crore girls, based on RGI 2021 population estimates [1].
  • Six States are at 100% coverage: Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar [1].
  • Uttar Pradesh has the highest absolute number, with more than 29.33 lakh girls vaccinated [1].

3. Background & Evolution

  • 2018: The National NCD Portal was rolled out under NP-NCD for screening and managing NCDs, including cervical cancer. People aged 30 and above are referred for screening of common NCDs [8].
  • 2020: The World Health Assembly adopted WHO's Global Strategy to Accelerate the Elimination of Cervical Cancer, with the 90-70-90 targets for 2030 [4].
  • April 2022: WHO's SAGE concluded that a single dose gives protection comparable to a 2-dose schedule [5].
  • 10 Sep 2024: 57 countries were using the single-dose schedule [5].
  • Oct 2024: WHO confirmed Cecolin, the 4th WHO-prequalified HPV vaccine, for single-dose use [5].
  • Dec 2024: A Lok Sabha reply said CERVAVAC is India's first indigenously developed cervical cancer vaccine. It also said the HPV vaccine was not then part of the Universal Immunization Programme (UIP) [7].
  • 28 Feb 2026: The PM launched the nationwide campaign from Ajmer, Rajasthan. The target at launch was about 1.15 crore girls aged 14 [2][3].
  • Earlier State initiatives: Bihar, Tamil Nadu and Sikkim had their own programmes, now integrated with the national campaign [1].
  • 21 Nov 2026: The 1 crore dose milestone was announced [1].

4. Core Static Facts

Item Fact
Campaign National HPV Vaccination Campaign [1]
Ministry Ministry of Health and Family Welfare [1]
Launched February 2026 (28 Feb), by the PM, from Ajmer [1][2][3]
Beneficiaries 14-year-old girls [1]
Dose / terms Single dose; free, safe, voluntary; parental consent [1]
Venue Government health facilities, under trained Medical Officers [1]
Safety AEFI (Adverse Events Following Immunization) framework; sites linked to 24×7 healthcare centres [1]
Who is not vaccinated Pregnant girls; girls with yeast allergy or a past allergic reaction to a vaccine; girls already given any HPV vaccine (Gardasil, Cervarix, Cervavac) [2]
Digital backbone U-WIN: real-time monitoring, beneficiary tracking, slot booking, downloadable certificates [1]
Target cohort About 1.2 crore girls a year (RGI 2021); about 1.15 crore cited at launch [1][2]
Doses given More than 1 crore in under 9 months [1]
Coverage Nearly 87% cumulative [1]
Global evidence More than 800 million doses given worldwide; nearly two decades of research [1]
Frontline workers ASHAs, ANMs, teachers, doctors (including AIIMS specialists) [1]
Indigenous vaccine CERVAVAC, India's first [7]
WHO 2030 targets 90% of girls fully vaccinated by age 15; 70% of women screened with a high-performance test by 35 and again by 45; 90% of women with cervical disease treated [4]

5. Multi-Dimensional Analysis

Social / Gender

  • The campaign targets a cancer that affects only women. It is free and consent-based, which supports equity and acceptance [1].
  • Vaccinating at age 14, before likely exposure to HPV, protects future generations of women [1].
  • Consent and misinformation are real barriers. ASHAs, ANMs, teachers and AIIMS doctors are used to build trust [1].

Administrative / Federal

  • This is cooperative federalism: the Union, States/UTs and district administrations work together, and States adapt delivery to rural, remote and urban areas [1].
  • State programmes (Bihar, Tamil Nadu, Sikkim) were merged into the national campaign rather than duplicated [1].
  • Coverage varies across States. Six are at 100% while the national figure is about 87%, so lagging States need targeted catch-up [1].

Scientific / Technological

  • A single-dose schedule is supported by WHO SAGE evidence (2022). It lowers cost and logistics compared with 2-dose schedules [5].
  • CERVAVAC gives India its own source of the vaccine, which matters for supply security and Atmanirbharta [7].
  • U-WIN digital records let managers find unvaccinated eligible girls at district level [1].

Governance / Ethics

  • Transparency: parents can book slots and download certificates online [1].
  • Safety accountability: the AEFI protocols, Medical Officer supervision and 24×7 links address the ethics of vaccinating minors [1].
  • Parental consent balances the public health goal against family autonomy [1].

Global / Strategic

  • The campaign moves India toward the "90" vaccination pillar of WHO's elimination strategy [4].
  • Other countries are also accelerating: Indonesia has set 90-75-90 targets, and Rwanda aims to meet 90-70-90 by 2027 [6].
  • Global single-dose coverage among girls aged 9-14 was only 27% in 2023 (up from 20% in 2022). India's 87% cohort coverage compares well [5][1].

Economic

  • A single dose and existing UIP-style delivery points keep the cost per girl low.
  • Prevention avoids future spending on cancer treatment, which can be catastrophic for households. (Analytical point; no official figures cited.)

6. Recent Developments (last 12-18 months)

  • 17 Nov 2025: WHO marked Cervical Cancer Elimination Day. It highlighted countries speeding up action, including Indonesia (90-75-90) and Rwanda (target year 2027) [6].
  • 28 Feb 2026: The National HPV Vaccination Campaign was launched from Ajmer for about 1.15 crore girls aged 14 [2][3].
  • 21 Nov 2026: The 1 crore dose milestone was announced. Coverage is about 87%, six States are at 100%, and UP leads with more than 29.33 lakh girls [1].

7. Prelims Hooks

  • The campaign gives HPV vaccine to 14-year-old girls, as a single dose [1].
  • It is free and voluntary, and requires parental consent [1].
  • It was launched in February 2026 by the PM from Ajmer, Rajasthan [1][3].
  • More than 1 crore doses were given in under nine months [1].
  • The target cohort is about 1.2 crore girls a year, based on RGI 2021 estimates [1].
  • The States at 100% coverage are Gujarat, UP, AP, Mizoram, MP and Bihar [1].
  • Uttar Pradesh has the most girls vaccinated in absolute terms (more than 29.33 lakh) [1].
  • U-WIN handles monitoring, tracking, slot booking and certificates [1].
  • CERVAVAC is India's first indigenously developed cervical cancer vaccine [7].
  • WHO's elimination targets are 90-70-90, to be met by 2030, and the strategy was adopted by the WHA in 2020 [4].
  • The "90" vaccination target means girls fully vaccinated by age 15 [4].
  • WHO SAGE (April 2022) found that a single dose protects about as well as two [5].
  • Cecolin is the 4th WHO-prequalified HPV vaccine cleared for single-dose use (Oct 2024) [5].
  • More than 800 million HPV doses have been given worldwide [1].

8. Who the 87% Leaves Out: Girls Already Past 14

  • The campaign covers only one age group each year
  • Only girls who are 14 are vaccinated [1].
  • A cohort (the group of people born in the same year) of about 1.2 crore girls is the yardstick for the 87% [1].
  • A girl who was 15, 16 or 17 when the campaign began in February 2026 was never eligible. Unless there is a catch-up round (a one-time drive for older ages), she will never be eligible.

  • WHO allows a wider age band than India uses

  • WHO's December 2022 advice allows a one- or two-dose schedule for girls aged 9-14, and also for girls and young women aged 15-20 [11].
  • WHO's HPV page reports that in October 2026 SAGE (WHO's Strategic Advisory Group of Experts on immunisation) strengthened its support for one dose and extended it to people up to 30 years of age. An updated position paper is expected in 2027 [15].
  • India has chosen one year of age. That is cheaper and easier to run, but it leaves several older age groups unprotected.

  • The size of the gap

  • The IARC (WHO's cancer research agency) put India's girls aged 9-14 at roughly 5 crore [12].
  • The national campaign reaches about 1.2 crore of them a year, all aged 14 [1].

  • '100% coverage' is measured against an estimate, not a headcount

  • The cohort size comes from RGI 2021 population projections (estimates of how many people there will be) [1].
  • If a State's real number of 14-year-olds differs from the projection, its coverage figure is off by the same amount. A '100%' State has met its estimated target. That does not prove every girl there was reached.
  • On the same figures, about 13% of the national cohort is still unvaccinated. That is roughly 15 lakh girls [1].

9. Why Vaccinating Girls Cannot Meet the 2030 Target by Itself

  • The vaccine helps women only decades later
  • The girls vaccinated today are 14. Cervical cancer mostly appears in adult women.
  • So almost none of the cancers expected by 2030 will be stopped by this campaign. Women who are already adults are protected only by screening (a test to catch early disease) and treatment. These are the '70' and second '90' of WHO's 90-70-90 targets [4].

  • Screening is the weakest of the three pillars

  • WHO's India profile says fewer than 1 in 10 women had been screened for cervical cancer in the previous five years [9].
  • The Government's own count is higher. By 20 July 2025, 10.18 crore women had been screened, out of 25.42 crore eligible women aged 30 and above. That is about 40% [10].
  • The two numbers measure different things. The Government figure is a running total of screenings recorded on the National NCD Portal [10]. WHO's figure counts women screened within the last five years [9].

  • India mostly uses a test that WHO's target does not count

  • India's main screening test is VIA (visual inspection with acetic acid: a health worker applies a mild acid to the cervix and looks for colour changes) [9].
  • WHO's '70' target counts only a high-performance test, meaning one as good as an HPV test, given by age 35 and again by 45 [4].
  • The Union Minister of Science and Technology has said the current methods (VIA/VILI, Pap smear and HPV DNA testing) are costly, need many resources and are only moderately sensitive, meaning they miss some cases [13].
  • So even a high screening count may not meet the WHO standard.

10. Is One Dose Really Enough?

  • The strongest objection
  • HPV vaccines were first licensed for two or three doses.
  • WHO's 2022 recommendation calls the single-dose schedule an off-label option. Off-label means it differs from the dosing on the manufacturer's licence [11].
  • Critics ask whether protection from one dose will last until the risky ages, which are 20 to 30 years away for a 14-year-old.

  • What is right about it

  • Vaccines have been used at scale for only about two decades [1]. So nobody yet has 30 years of follow-up for one dose.

  • Why the evidence still supports India's choice

  • WHO found that one dose gives efficacy (how well it prevents infection) and durability (how long protection lasts) comparable to two doses [11][5].
  • 57 countries were already using one dose by September 2024 [5]. WHO's HPV page reports a stronger single-dose recommendation in October 2026 [15].
  • For India, one dose made it possible to reach about 1 crore girls in under nine months [1].
  • IARC modelling found that a single-dose national programme in India could prevent almost 10 lakh cervical cancer cases over the lifetime of one cohort vaccinated at age 10 [12].
  • The fair conclusion: India is right to use one dose, but MoHFW should keep following vaccinated girls to check that protection lasts.

11. What Must Come After the Milestone

  • MoHFW should make HPV vaccination routine, not a one-off campaign
  • As of December 2024 the HPV vaccine was not part of the Universal Immunization Programme (UIP) [7].
  • A new group of girls turns 14 every year. Only the UIP gives a vaccine a permanent place in the annual budget and the routine schedule. A campaign can end when attention moves elsewhere.

  • MoHFW should run a one-time catch-up for girls aged 15-20

  • WHO's 2022 advice already allows one dose for this age group [11].
  • Mission Indradhanush is India's own model for catch-up drives that find children missed by routine vaccination.

  • MoHFW should move screening from VIA to HPV DNA tests

  • MoHFW reports that an indigenous point-of-care HPV DNA test (a test done on the spot, without a central laboratory) has been validated, which supports screening closer to home [14].
  • The Union Minister of Science and Technology held a review of indigenous HPV test kits with DBT, AIIMS, BIRAC, ICMR and industry [13].
  • Rolling these kits out at Ayushman Arogya Mandirs would help India meet WHO's 'high-performance test' standard [4].

  • Link U-WIN records to the National NCD Portal

  • U-WIN already records each vaccinated girl [1]. The NCD Portal tracks screening for adults [8].
  • If the two were linked, a woman vaccinated today could be called for screening automatically at 30. It would also let India measure, over the years, how much the vaccine lowers disease.

12. Anchors for Answers

  • Data: Fewer than 1 in 10 Indian women screened for cervical cancer in the previous 5 years (WHO country profile, 2021) [9]
  • Data: 10.18 crore of 25.42 crore eligible women aged 30+ screened as of 20 July 2025 (National NCD Portal count) [10]
  • Data: A single-dose national programme could prevent almost 10 lakh cervical cancer cases over one cohort's lifetime (IARC) [12]
  • Report/Committee: WHO SAGE single-dose finding, April 2022 [5]; WHO HPV recommendations, December 2022, allowing one or two doses for ages 9-14 and 15-20 [11]; WHO Global Strategy (90-70-90), 2020 [4]
  • Comparison: Rwanda aims to meet 90-70-90 by 2027; Indonesia has set its own 90-75-90 targets [6]
  • Scheme: NP-NCD / National NCD Portal, the screening ('70') pillar [8]; UIP, which HPV was outside as of Dec 2024 [7]; Mission Indradhanush, a model for catch-up drives

13. Mains Relevance

14. Related Topics to Study Next

  • Universal Immunization Programme (UIP): HPV was outside the UIP as of Dec 2024 [7]. Track whether it has since been added.
  • U-WIN vs Co-WIN: the digital immunisation registry used for this campaign.
  • NP-NCD / National NCD Portal (2018): screening is the "70" pillar of 90-70-90 [8].
  • Ayushman Arogya Mandirs: the primary care sites where screening is delivered.
  • WHO Cervical Cancer Elimination Initiative: the global framework for India's targets [4].
  • AEFI surveillance system: the vaccine safety governance behind the campaign.
  • CERVAVAC and India's vaccine manufacturing: indigenous capacity and self-reliance in vaccines.
  • Mission Indradhanush: a precedent for catch-up immunisation drives.

15. NCERT Concepts to Revise

  • Vaccine hesitancy (Economy): Consent concerns and misinformation are named barriers; ASHAs and teachers are used to build parental trust.
  • World Health Organization (Polity): WHO's 90-70-90 strategy, SAGE single-dose advice and vaccine prequalification frame India's campaign.
  • Cooperative federalism (Polity): Union, States and districts jointly delivered the campaign, merging earlier State programmes into one national drive.
  • Digital public infrastructure (Polity): U-WIN tracks beneficiaries, books slots and issues certificates, showing digital platforms delivering health services at scale.
  • Mission Indradhanush (Economy): India's model for catch-up immunisation drives, suggested for girls older than 14 who were missed.
  • Non-communicable disease (Economy): Cervical cancer is an NCD; screening runs through NP-NCD and the National NCD Portal.
  • Screening (Economy): Needs care: this entry is the economics sense, not medical screening, so only a loose link to the note's screening pillar.
  • Registrar General of India (Polity): The 87% coverage and 1.2 crore cohort rest on RGI 2021 population estimates, not a headcount.
  • Self-reliance (Economy): CERVAVAC gives India its own vaccine supply, supporting Atmanirbharta and supply security.
  • Equity (Geography): Free vaccination of girls and State-wise coverage gaps raise questions of equal access to health care.
  • Governance (Polity): Transparency, safety monitoring (AEFI) and consent for minors make this a governance and ethics case.

16. Common Errors / Trap Areas

  • Doses vs coverage: "1 crore" counts doses; "about 87%" is coverage of the annual cohort. They are different measures [1].
  • Absolute vs percentage: UP leads in absolute numbers and is also one of the six States at 100%. Do not assume the State with the most girls vaccinated is the only one at full coverage [1].
  • Cohort figure: about 1.15 crore at launch [2] and about 1.2 crore in the Nov 2026 release [1]. Both are RGI-based estimates, so note which release a question is quoting.
  • Age: the campaign is for 14 years. WHO's target is "by age 15" [1][4]. Do not write 9-14 or 9-26 for the Indian campaign.
  • Targets: WHO's are 90-70-90 [4]; Indonesia's national version is 90-75-90 [6]. Do not mix them up.
  • Dose schedule: India's campaign is single-dose. Older 2- and 3-dose schedules are not the campaign design [1][5].

Sources

  1. 1PIB: India crosses 1 crore HPV vaccine doses (release digest supplied by user)pib.gov.in · tier 1
  2. 2PIB document: free nationwide HPV vaccination campaign for girls aged 14 (Feb 2026)static.pib.gov.in · tier 1
  3. 3New India Samachar (PIB), 16-31 March 2026, page 10newindiasamachar.pib.gov.in · tier 1
  4. 4WHO: Global strategy to accelerate the elimination of cervical cancer as a public health problemwho.int · tier 2
  5. 5WHO: WHO adds an HPV vaccine for single-dose use (4 Oct 2024)who.int · tier 2
  6. 6WHO: World marks Cervical Cancer Elimination Day as countries accelerate action (17 Nov 2025)who.int · tier 2
  7. 7Lok Sabha Unstarred Question AU3001 (CERVAVAC; HPV vaccine and UIP status)eparlib.sansad.in · tier 1
  8. 8Lok Sabha Starred Question AS180 (National NCD Portal, NP-NCD screening)eparlib.sansad.in · tier 1
  9. 9WHO: India Cervical Cancer Profile (2021)cdn.who.int · tier 2
  10. 10PIB: 10.18 Crore Women Screened for Cervical Cancer Under Ayushman Arogya Mandirs and NHMpib.gov.in · tier 1
  11. 11WHO: WHO updates recommendations on HPV vaccination schedule (20 Dec 2022)who.int · tier 2
  12. 12IARC (WHO): Protection from a Single Dose of HPV Vaccine, Evidence Summary Brief 4iarc.who.int · tier 2
  13. 13PIB: Dr. Jitendra Singh reviews indigenously developed HPV test kits for cervical cancer screeningpib.gov.in · tier 1
  14. 14PIB: Ministry of Health & Family Welfare Initiatives & Achievements 2025static.pib.gov.in · tier 1
  15. 15WHO: Human Papillomavirus (HPV) vaccine (immunization team page) — )who.int · tier 2
At the end · practice MCQs
8 questions on this item
Check the answer for each question, or reveal all at once.
Practice MCQs →

Mains Q&A on this note

NCERT concepts in this note